Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.59 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 7/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | ACE | P12821 | 7/20 | 0.50 |
| ▸ | CPA1 | P15085 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3983123 | 1.00 | FOLH1 (0.59) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL9847993 | 0.84 | FOLH1 (0.54) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL9847998 | 0.84 | FOLH1 (0.54) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL5738141 | 0.84 | FOLH1 (0.61) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL12869808 | 0.84 | FOLH1 (0.61) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL5869469 | 0.83 | FOLH1 (0.74) | FOLH1NAALAD2MMEACECPA1 | |
| SCHEMBL5869992 | 0.83 | FOLH1 (0.74) | FOLH1NAALAD2MMEACECPA1 | |
| SCHEMBL22612664 | 0.83 | FOLH1 (0.60) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL29444963 | 0.83 | FOLH1 (0.60) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL156975 | 0.81 | FOLH1 (0.58) | FOLH1NAALAD2SLC7A5MMEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115997121-A | Composition for endometriosis assessment with improved specificity | 艾思彼拉妇女保健公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-105823877-B | Biomarkers for ovarian cancer: CTAP 3-related protein | 约翰·霍普金斯大学 | 2022-02-25 | — | — | CN | disclosed |
| US-20170089906-A1 | BIOMARKERS FOR OVARIAN CANCER | VERMILLION, INC. (US) | 2017-03-30 | — | — | US | disclosed |
| CN-105823877-A | Biomarker for ovarian cancer CTAP3-related proteins | 约翰·霍普金斯大学 | 2016-08-03 | — | — | CN | disclosed |
| CN-101243319-B | Biomarkers for ovarian cancer: CTAP 3-related protein | THE JOHNS HOPKINS UNIVERSITY (US) | 2016-01-06 | — | — | CN | disclosed |
| US-20140038899-A1 | BIOMARKERS FOR OVARIAN CANCER | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-02-06 | — | — | US | disclosed |
| EP-1910821-B1 | BIOMARKERS FOR OVARIAN CANCER | CIPHERGEN BIOSYSTEMS INC (US) | 2013-02-20 | — | — | EP | disclosed |
| EP-1910821-A4 | BIOMARKERS FOR OVARIAN CANCER | CIPHERGEN BIOSYSTEMS INC (US) | 2009-05-13 | — | — | EP | disclosed |
| US-20080274481-A1 | Methods for diagnosing ovarian cancer | VERMILLION, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| WO-2008121340-A1 | METHODS FOR DIAGNOSING OVARIAN CANCER | VERMILLION, INC. (US) | 2008-10-09 | — | — | WO | disclosed |
| EP-1910821-A2 | BIOMARKERS FOR OVARIAN CANCER | Ciphergen Biosystems, Inc. (US) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007002535-A2 | BIOMARKERS FOR OVARIAN CANCER | CIPHERGEN BIOSYSTEMS, INC. (US) | 2007-01-04 | — | — | WO | disclosed |